2020
DOI: 10.3390/pharmacy8030156
|View full text |Cite
|
Sign up to set email alerts
|

Long-Lasting, Patient-Controlled, Procedure-Free Contraception: A Review of Annovera with a Pharmacist Perspective

Abstract: Annovera (segesterone acetate and ethinyl estradiol vaginal system) is a US Food and Drug Administration FDA-approved long-lasting, reversible contraceptive that is fully administered by the user and does not require a procedure for insertion or removal. The vaginal system is in the shape of a ring and contains low doses of a novel progestin, egesterone acetate, and ethinyl estradiol. It is made of silicone and is fully pliable and flexible. The vaginal system is reusable for 13 cycles, using a 21 days in/7 da… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 22 publications
0
2
0
Order By: Relevance
“…16 No backup contraception is needed if the intravaginal ring is reinserted within 2 hours of expulsion. 17 This may not be an appropriate method for those with diffi culty or pain using the vaginal ring, such as those with arthritis of the hands, pelvic fl oor dysfunction, vaginismus, preference to avoid intravaginal placement, or other limitations for correct use.…”
Section: ■ Intravaginal Ringmentioning
confidence: 99%
“…16 No backup contraception is needed if the intravaginal ring is reinserted within 2 hours of expulsion. 17 This may not be an appropriate method for those with diffi culty or pain using the vaginal ring, such as those with arthritis of the hands, pelvic fl oor dysfunction, vaginismus, preference to avoid intravaginal placement, or other limitations for correct use.…”
Section: ■ Intravaginal Ringmentioning
confidence: 99%
“…Continuous extrusion processes are controlled by the hot melt extruder panel, and the extrudate could be pelletized, milled, mixed and 3D printed to dosage forms such as tablets, film, granules, capsules, and so on, which promotes the scalability of this technology. Several HME commercial products approved by the Food and Drug Administration (FDA), currently available in the market with different release targets, prove the potential and success of this technology [ 24 , 25 , 26 , 27 ].…”
Section: Introductionmentioning
confidence: 99%